Literature DB >> 17653567

The prevalence of retinal angiomatous proliferation in age-related macular degeneration with occult choroidal neovascularization.

Amedeo L Massacesi1, Laura Sacchi, Fulvio Bergamini, Ferdinando Bottoni.   

Abstract

BACKGROUND: The purpose of the study was to ascertain the prevalence of retinal angiomatous proliferation (RAP) by means of dynamic indocyanine green angiography (d-ICGA) in patients with newly diagnosed fibrovascular pigment epithelium detachment (type 1) or late leakage of undetermined source (type 2) occult choroidal neovascularization (CNV) on fluorescein angiography.
METHODS: We carried out a review of digital fluorescein and ICG angiograms obtained by confocal scanning laser ophthalmoscope (HRA; Heidelberg Engineering GmbH, Dossenheim, Germany) in 253 consecutive patients (270 eyes) with a clinical diagnosis of type 1 or type 2 occult CNV on fluorescein angiography (1998 through 2003).
RESULTS: Sixty eyes had type 1 and 210 eyes type 2 occult CNV on fluorescein angiography. Overall, 57 cases of RAP were identified in 54 eyes (20%) with d-ICGA. RAP was present in 6 out of 60 eyes with type 1 (10%) and in 51 out of 210 eyes with type 2 occult CNV (24%). Mean distance of the lesion from the fovea was 682 +/- 304 microm (mean +/- SD).
CONCLUSIONS: d-ICGA is invaluable for early diagnosis of RAP in exudative age-related macular degeneration (ARMD). In our series, up to one fourth of type 2 occult CNV were in fact RAP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653567     DOI: 10.1007/s00417-007-0638-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

1.  Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation.

Authors:  Ferdinando Bottoni; Amedeo Massacesi; Mario Cigada; Francesco Viola; Ilenia Musicco; Giovanni Staurenghi
Journal:  Arch Ophthalmol       Date:  2005-12

2.  Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1991-09

3.  Retinal angiomatous proliferation treated with a combination of intravitreal triamcinolone acetonide and photodynamic therapy with verteporfin.

Authors:  I Mantel; A Ambresin; L Zografos
Journal:  Eur J Ophthalmol       Date:  2006 Sep-Oct       Impact factor: 2.597

4.  A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy.

Authors:  Ilse Krebs; Susanne Binder; Ulrike Stolba
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-06       Impact factor: 3.117

5.  Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy.

Authors:  Ferdinando Bottoni; Mary Romano; Amedeo Massacesi; Fulvio Bergamini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-04-12       Impact factor: 3.117

6.  Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration.

Authors:  J S Slakter; L A Yannuzzi; U Schneider; J A Sorenson; A Ciardella; D R Guyer; R F Spaide; K B Freund; D A Orlock
Journal:  Ophthalmology       Date:  2000-04       Impact factor: 12.079

7.  Angiographic and flow patterns of retinal choroidal anastomoses in age-related macular degeneration with occult choroidal neovascularization.

Authors:  Ruth Axer-Siegel; Dan Bourla; Ethan Priel; Yuval Yassur; Dov Weinberger
Journal:  Ophthalmology       Date:  2002-09       Impact factor: 12.079

8.  Digital indocyanine green videoangiography and choroidal neovascularization.

Authors:  L A Yannuzzi; J S Slakter; J A Sorenson; D R Guyer; D A Orlock
Journal:  Retina       Date:  1992       Impact factor: 4.256

9.  Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.

Authors:  Massimo Nicolò; Davidina Ghiglione; Silvio Lai; Giovanni Calabria
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-08       Impact factor: 3.117

10.  Digital indocyanine-green videoangiography of occult choroidal neovascularization.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; M Hope-Ross; D R Orlock
Journal:  Ophthalmology       Date:  1994-10       Impact factor: 12.079

View more
  7 in total

1.  Treatment of recurrent retinal angiomatous proliferation with intravitreal triamcinolone acetonide followed by photodynamic therapy with verteporfin: A retrospective case series.

Authors:  Nicola Cardascia; Claudio Furino; Andrea Ferrara; Francesco Boscia; Giovanni Alessio
Journal:  Curr Ther Res Clin Exp       Date:  2009-06

2.  RETINAL ANGIOMATOUS PROLIFERATION CASE REPORT.

Authors:  Andrei Olaru; Denissa-Greta Olaru; Andreea Nicolcescu; Cristian Olaru; Mihaela Popescu; Andreea-Gabriela Deca; Carmen Mocanu
Journal:  Rom J Ophthalmol       Date:  2015 Jul-Sep

3.  Focal choroidal excavation: a preliminary interpretation based on clinic and review.

Authors:  Guang-Hui Liu; Bing Lin; Xin-Quan Sun; Zi-Fang He; Ji-Rong Li; Rong Zhou; Xiao-Ling Liu
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

4.  [Anti-VEGF treatment for retinal angiomatous proliferation].

Authors:  A Wolf; D Kook; T Kreutzer; A Gandorfer; C Haritoglou; A Kampik; M Ulbig
Journal:  Ophthalmologe       Date:  2008-09       Impact factor: 1.059

5.  The RAP study, report 3: Discoloration of the macular region in patients with macular neovascularization type 3.

Authors:  Bilal Haj Najeeb; Gabor G Deak; Ursula Schmidt-Erfurth; Bianca S Gerendas
Journal:  Acta Ophthalmol       Date:  2021-04-05       Impact factor: 3.988

6.  Systemic Inflammation by Collagen-Induced Arthritis Affects the Progression of Age-Related Macular Degeneration Differently in Two Mouse Models of the Disease.

Authors:  Gloriane Schnabolk; Elisabeth Obert; Nirmal K Banda; Bärbel Rohrer
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.799

7.  Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab response.

Authors:  Katja Hatz; Christian Prünte
Journal:  Br J Ophthalmol       Date:  2013-11-18       Impact factor: 4.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.